Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 32

Trial Status

Completed1
Terminated2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT01875874Phase 2Terminated
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
Acute Liver FailureFulminant Hepatic FailurePrimary Graft Non-Function+1 more
Principalinvestigator

Research Network

Collaboration Network

84 collaborators·128 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Talal Adhami, MD

OH - Cleveland Clinic Foundation

Similar
4 trials

Shared therapeutic areas:

Acute Alcoholic HepatitisLiver Failure, AcuteLiver Failure, Fulminant+2 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 3 trials
Similarity Score62%

Ram Subramanian, MD

GA - Emory University Hospital

Similar
4 trials

Shared therapeutic areas:

Acute Alcoholic HepatitisLiver Failure, AcuteLiver Failure, Fulminant+2 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 3 trials
Similarity Score62%

Lance Stein, MD

GA - Piedmont Atlanta Hospital

Similar
3 trials

Shared therapeutic areas:

Acute Alcoholic HepatitisLiver Failure, AcuteLiver Failure, Fulminant+2 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 2 trials
Similarity Score58%

Angel Alsina, MD

FL - Tampa General Hospital

Similar
2 trials

Shared therapeutic areas:

Acute Alcoholic HepatitisLiver Failure, AcuteLiver Failure, Fulminant+2 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 2 trials
Similarity Score58%

David J Reich, MD

PA - Drexel University College of Medicine

Similar
2 trials

Shared therapeutic areas:

Acute Alcoholic HepatitisLiver Failure, AcuteLiver Failure, Fulminant+2 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 2 trials
Similarity Score58%

Julie Thompson, MD

MN - University of Minnesota Medical Center - Twin Cities Campus

Similar
3 trials

Shared therapeutic areas:

Acute Alcoholic HepatitisLiver Failure, AcuteLiver Failure, Fulminant+2 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 2 trials
Similarity Score58%

Kalyan R Bhamidimarri, MD

FL - University of Miami Hospital

Similar
3 trials

Shared therapeutic areas:

Acute Alcoholic HepatitisLiver Failure, AcuteLiver Failure, Fulminant+2 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 2 trials
Similarity Score58%

Rohit Satoskar, MD

DC - Georgetown University Hospital

Similar
3 trials

Shared therapeutic areas:

Acute Alcoholic HepatitisLiver Failure, AcuteLiver Failure, Fulminant+2 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 2 trials
Similarity Score58%

Winfred W Williams, Jr., MD

MA - Massachusetts General Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Liver Failure, AcuteLiver Failure, FulminantPrimary Graft Non-Function+1 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 1 trial
Similarity Score44%

Lewis W Teperman, MD

NY - New York University Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

Liver Failure, AcuteLiver Failure, FulminantPrimary Graft Non-Function+1 more

Worked with same sponsors:

Vital Therapies, Inc.
Collaborated on 1 trial
Similarity Score44%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT02612428Phase 3PrincipalInvestigator

Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD

Acute Alcoholic Hepatitis
Terminated
NCT01471028Phase 3PrincipalInvestigator

Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure

Acute Alcoholic Hepatitis
Completed
NCT01875874Phase 2PrincipalInvestigator

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

Acute Liver FailureFulminant Hepatic FailurePrimary Graft Non-Function+1 more
Terminated

All 3 trials loaded